3

PRIMARY DOCUMENT

Company: NovaBay Pharmaceuticals, Inc.
Filed: January 2, 2013
Period of Report: September 13, 2012
Accession Number: 0001437749-13-000026

View Document ↗ View on SEC.gov ↗